251 related articles for article (PubMed ID: 3102675)
21. Human T cell rosetting is mediated by LFA-3 on autologous erythrocytes.
Makgoba MW; Shaw S; Gugel EA; Sanders ME
J Immunol; 1987 Jun; 138(11):3587-9. PubMed ID: 3108368
[No Abstract] [Full Text] [Related]
22. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.
Sanders ME; Makgoba MW; Sussman EH; Luce GE; Cossman J; Shaw S
Cancer Res; 1988 Jan; 48(1):37-40. PubMed ID: 3275493
[TBL] [Abstract][Full Text] [Related]
24. Activation of human T lymphocytes through CD3 and CD2 (T11) with anti-CD3-coupled sheep erythrocytes.
Ocklind G
Scand J Immunol; 1988 May; 27(5):609-13. PubMed ID: 2897712
[TBL] [Abstract][Full Text] [Related]
25. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation.
Hünig T; Tiefenthaler G; Mitnacht R; Köhler C; Lottspeich F; Meuer S
Behring Inst Mitt; 1987 Jun; (81):31-40. PubMed ID: 2888455
[TBL] [Abstract][Full Text] [Related]
26. Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation.
Bierer BE; Peterson A; Barbosa J; Seed B; Burakoff SJ
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1194-8. PubMed ID: 2448792
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies against human T cell adhesion molecules--modulation of immune function in nonhuman primates.
Berlin PJ; Bacher JD; Sharrow SO; Gonzalez C; Gress RE
Transplantation; 1992 Apr; 53(4):840-9. PubMed ID: 1348883
[TBL] [Abstract][Full Text] [Related]
28. Purified lymphocyte function-associated antigen-3 (LFA-3) activates human thymocytes via the CD2 pathway.
Denning SM; Dustin ML; Springer TA; Singer KH; Haynes BF
J Immunol; 1988 Nov; 141(9):2980-5. PubMed ID: 2459236
[TBL] [Abstract][Full Text] [Related]
29. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
30. Evidence for cell surface association of CD2 and LFA-1 (CD11a/CD18) on T lymphocytes.
Altin JG; Pagler EB; Parish CR
Eur J Immunol; 1994 Feb; 24(2):450-7. PubMed ID: 7905418
[TBL] [Abstract][Full Text] [Related]
31. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989
[TBL] [Abstract][Full Text] [Related]
32. Serologic cross-reactivity of T11 target structure and lymphocyte function-associated antigen 3. Evidence for structural homology of the sheep and human ligands of CD2.
Tiefenthaler G; Dustin ML; Springer TA; Hünig T
J Immunol; 1987 Oct; 139(8):2696-701. PubMed ID: 2443569
[TBL] [Abstract][Full Text] [Related]
33. Only dull CD3+ thymocytes bind to thymic epithelial cells. The binding is elicited by both CD2/LFA-3 and LFA-1/ICAM-1 interactions.
Nonoyama S; Nakayama M; Shiohara T; Yata J
Eur J Immunol; 1989 Sep; 19(9):1631-5. PubMed ID: 2477252
[TBL] [Abstract][Full Text] [Related]
34. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
[TBL] [Abstract][Full Text] [Related]
35. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.
Koyasu S; Lawton T; Novick D; Recny MA; Siliciano RF; Wallner BP; Reinherz EL
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2603-7. PubMed ID: 1690889
[TBL] [Abstract][Full Text] [Related]
36. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
Hünig T; Tiefenthaler G; Meyer zum Büschenfelde KH; Meuer SC
Nature; 1987 Mar 19-25; 326(6110):298-301. PubMed ID: 3102975
[TBL] [Abstract][Full Text] [Related]
37. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.
Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A
J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194
[TBL] [Abstract][Full Text] [Related]
38. Functional CD2 mutants unable to bind to, or be stimulated by, LFA-3.
Wolff HL; Burakoff SJ; Bierer BE
J Immunol; 1990 Feb; 144(4):1215-20. PubMed ID: 1689346
[TBL] [Abstract][Full Text] [Related]
39. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
40. Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes.
Scheeren RA; Koopman G; Van der Baan S; Meijer CJ; Pals ST
Eur J Immunol; 1991 May; 21(5):1101-5. PubMed ID: 1709862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
